KP
Kush Parmar
10% Owner

Kush Parmar insider trades: Skye Bioscience (SKYE) stock buys and sales

10% Owner, Skye Bioscience Last trade Sep 23, 2026 85 Form 4 filings
$4.1M
Sold, last 12 months
10 sales
$0
Bought, last 12 months
0 buys
66
Open-market trades
since 2018
19
Companies
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Kush reports to the SEC

and 13 more companies

Open-market buys and sales

66 trades reported on SEC Form 4, newest first

DateStockTypeValue
Sep 23, 2026SKYE↓ Sell$230K
Sep 23, 2026SKYE↓ Sell$9K
Sep 16, 2026SKYE↓ Sell$62K
Sep 16, 2026SKYE↓ Sell$2K
Aug 20, 2026SKYE↓ Sell$118K
Aug 20, 2026SKYE↓ Sell$21K
Aug 20, 2026SKYE↓ Sell$853
Aug 10, 2026TRDA↓ Sell$1.1M
Jul 31, 2026TRDA↓ Sell$807K
Nov 14, 2025TRDA↓ Sell$1.8M
Sep 11, 2025CAMP↑ Buy$4.5M
Aug 22, 2025SKYE↓ Sell$770K
Aug 22, 2025SKYE↓ Sell$30K
Jul 9, 2025TRDA↓ Sell$151K
Jul 9, 2025TRDA↓ Sell$52K
Jul 1, 2025TRDA↓ Sell$644K
Jul 1, 2025TRDA↓ Sell$223K
Oct 15, 2024CAMP↑ Buy$10.0M
Sep 13, 2024SKYE↓ Sell$1.5M
Sep 13, 2024SKYE↓ Sell$253K
Sep 13, 2024SKYE↓ Sell$10K
Jul 22, 2024ARTV↑ Buy$10.0M
Mar 13, 2024SKYE↑ Buy$4.5M
Feb 14, 2024ELVN↓ Sell$10.3M
Feb 14, 2024ELVN↓ Sell$2.0M
Jan 31, 2024SKYE↑ Buy$12.0M
Jan 31, 2024ELVN↓ Sell$6.3M
Jan 31, 2024ELVN↓ Sell$1.2M
Sep 26, 2023ELVN↓ Sell$2.5M
Sep 26, 2023ELVN↓ Sell$491K
Aug 24, 2023ELVN↓ Sell$5.9M
Aug 24, 2023ELVN↓ Sell$1.2M
Mar 7, 2023RLYB↓ Sell$820K
Aug 15, 2022CINC↑ Buy$14.6M
Aug 15, 2022CINC↑ Buy$3.4M
Jun 3, 2022RLYB↓ Sell$1.2M
Jun 3, 2022RLYB↓ Sell$629K
May 23, 2022RLYB↓ Sell$864K
May 23, 2022RLYB↓ Sell$436K
Feb 8, 2022RLYB↓ Sell$1.8M
Feb 8, 2022RLYB↓ Sell$920K
Jan 11, 2022CINC↑ Buy$5.0M
Jan 11, 2022CINC↑ Buy$2.5M
Nov 16, 2021VOR↓ Sell$5.1M
Nov 2, 2021TRDA↑ Buy$5.0M
Nov 1, 2021CABA↓ Sell$3.8M
Sep 7, 2021CABA↓ Sell$6.1M
Aug 2, 2021RLYB↑ Buy$8.0M
Apr 27, 2021IMPL↑ Buy$8.6M
Feb 9, 2021VOR↑ Buy$10.0M

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other SKYE insiders

Open-market trades in the last 12 months

About Kush Parmar's insider trades

Kush Parmar is a 10% owner of Skye Bioscience (SKYE). Since Nov 16, 2018, Kush has reported 16 open-market purchases worth $113.2M and 50 sales worth $139.5M on SEC Form 4. In the last 12 months: 10 sales ($4.1M).

Their filings also include grants and awards (27 filings), conversions (11 filings), other transactions (11 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every SKYE insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.